uniQure N.V.

In News

QURE: uniQure NV Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Stocktwits - Sep 18, 2026

uniQure seeks US approval for Huntington's gene therapy after FDA reversal - Reuters

Reuters - Sep 02, 2026

UniQure N.V. (QURE) Stock Analysis: A Biotech Powerhouse With A 56% Upside Potential - DirectorsTalk Interviews

DirectorsTalk Interviews - Sep 18, 2026

uniQure stock holds recent gains as Huntington’s gene therapy filing reshapes outlook - AD HOC NEWS

AD HOC NEWS - Sep 20, 2026

uniQure Announces Submission of Biologics License - GlobeNewswire

GlobeNewswire - Sep 02, 2026

uniQure (QURE) Submitted AMT-130 for Accelerated Approval in Huntington’s Disease. Can Externally Controlled Data Support the Application? - Yahoo Finance

Yahoo Finance - Sep 08, 2026

What to expect from UniQure’s upcoming Huntington’s gene therapy readout - STAT

STAT - Sep 10, 2026

uniQure Submits BLA and MAA for AMT-130 Gene Therapy in Huntington's Disease - BioPharm International

BioPharm International - Sep 03, 2026

uniQure Filed for Huntington's Approval. Acceptance Is the Catalyst, Analyst Says - Benzinga

Benzinga - Sep 02, 2026

Morgan Lewis Advises uniQure on $259M Follow-On Offering – News - Morgan Lewis

Morgan Lewis - Jun 25, 2026

Why Is uniQure (QURE) Up 17.5% Since Last Earnings Report? - Yahoo Finance

Yahoo Finance - Aug 28, 2026

uniQure Announces Pricing of Upsized $225 Million Public Offering - GlobeNewswire

GlobeNewswire - Jun 23, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment